Press Release: DRUGSCAN : DRUGSCAN Develops In-Vitro Method to Assess Fentanyl Release when Fentanyl Transdermal Patches are Abused by Chewing

HORSHAM, Pa., Aug. 21, 2019 /PRNewswire/ -- DRUGSCAN® Pharmaceutical Services has developed an in-vitro method to assess the abuse-deterrent capabilities of transdermal fentanyl patches. Scientists at DRUGSCAN conducted an in-vitro mastication study to help pharmaceutical companies...